DCI Partners
Overview
DCI Partners is a venture capital firm based in Tokyo, Japan, that specializes in the life sciences, biotechnology, and drug discovery sectors with a focus on investments in Japan and Taiwan.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| OrthoRebirth Co., Ltd. | Sep 2011 | VC Round | Co-investor |
| aceRNA Technologies Co., Ltd. | May 2024 | Series B | Lead |
| Luxna Biotech Co., Ltd. | Sep 2024 | Series C | Lead |
| Neusignal Therapeutics, Inc. | Jun 2026 | Series B | Lead |
| SCOHIA PHARMA, Inc. | May 2026 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DCI Partners based?
DCI Partners is headquartered in Tokyo, Japan.
When was DCI Partners founded?
DCI Partners was founded in 2014.
How many portfolio companies does DCI Partners have?
DCI Partners has 11 portfolio companies in Caplight's dataset.
What are some companies in DCI Partners's portfolio?
Portfolio companies visible on Caplight include OrthoRebirth Co., Ltd., aceRNA Technologies Co., Ltd., Luxna Biotech Co., Ltd., Neusignal Therapeutics, Inc., SCOHIA PHARMA, Inc..
What was DCI Partners's most recent investment shown here?
DCI Partners's most recent investment in this portfolio sample was in Neusignal Therapeutics, Inc. in 2026.
What sectors does DCI Partners focus on?
DCI Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does DCI Partners focus on?
DCI Partners typically invests at the MultiStage stage.
What is DCI Partners's AUM?
DCI Partners's assets under management are estimated between $201.5M and $201.5M.